Last reviewed · How we verify

NCT07509762

Exercise Programs in Women With PCOS

Not yet recruiting NA Last updated 3 April 2026
What this trial tests

NA trial testing Face-to-face exercise in Polycystic Ovarian Syndrome (PCOS) in 33 participants. Not yet recruiting.

Timeline
1 September 2026
Primary endpoint
15 January 2027
25 March 2027

Quick facts

Lead sponsorBiruni University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment33
Start date1 September 2026
Primary completion15 January 2027
Estimated completion25 March 2027
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Biruni University

Who can join

Adults 18 to 40, female only, with Polycystic Ovarian Syndrome (PCOS) or Digital Rehabilitation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to investigate the effectiveness of a digital rehabilitation-supported combined exercise program in women with Polycystic Ovary Syndrome (PCOS). Participants aged 18-40 years will be randomly assigned to one of three groups: a digital rehabilitation group, a face-to-face exercise group, and a physical activity counseling group. The intervention will last 8 weeks, with exercise performed three times per week. Outcomes will include DNA methylation, hormonal and metabolic parameters, anthropometric measurements, body composition, muscle strength, basal metabolic rate, physical activity level, quality of life, menstrual cycle regularity, exercise adherence and satisfaction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Face-to-face exercise

Trials testing the same drug.

Other recruiting trials for Polycystic Ovarian Syndrome (PCOS)

Currently open trials in the same condition.

Other Biruni University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07509762.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing